Vaccinex, Inc.
VCNX- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001205922
No open-market purchases or sales by Vaccinex, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Vaccinex, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Of which not filed for Q2 2023 | Q2 2023 | Change |
|---|---|---|---|---|
| Holders | 24 | 1 | 23 | 0 |
| Shares | 2.76M | 10.0K | 2.82M | +70.6K (+2.6%) |
| Value | $1.10M | $4.00K | $994.8K | −$104.6K (−9.5%) |
1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (4)
Institutions that held Vaccinex, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 46,276 | $16.0K | 0.00% |
| Vectors Research Management, LLC | 10,000 | $4.00K | 0.00% |
| Courier Capital LLC | 10,000 | $3.56K | 0.00% |
| Cornerstone Planning Group LLC | 200 | $71 | 0.00% |
Sold out (4)
Institutions that held Vaccinex, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Millennium Management LLC | 111,098 | $44.0K |
| Virtu Financial LLC | 103,898 | $42.0K |
| Susquehanna International Group, LLP | 99,105 | $39.6K |
| Two Sigma Securities, LLC | 32,305 | $12.9K |
Not filed for Q2 2023 yet (1)
Institutions that held Vaccinex, Inc. at the end of Q1 2023 and haven't filed a 13F for Q2 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| HNP Capital LLC | 10,000 | $4.00K |